Shanghai OPM Biosciences Co Ltd
SSE:688293
Income Statement
Earnings Waterfall
Shanghai OPM Biosciences Co Ltd
Revenue
|
268.9m
CNY
|
Cost of Revenue
|
-104.8m
CNY
|
Gross Profit
|
164.1m
CNY
|
Operating Expenses
|
-100.9m
CNY
|
Operating Income
|
63.2m
CNY
|
Other Expenses
|
26.7m
CNY
|
Net Income
|
89.9m
CNY
|
Income Statement
Shanghai OPM Biosciences Co Ltd
Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | ||
---|---|---|---|---|---|---|
Revenue | ||||||
Revenue |
277
N/A
|
285
+3%
|
294
+3%
|
362
+23%
|
269
-26%
|
|
Gross Profit | ||||||
Cost of Revenue |
(101)
|
(104)
|
(106)
|
(130)
|
(105)
|
|
Gross Profit |
176
N/A
|
180
+2%
|
188
+4%
|
232
+23%
|
164
-29%
|
|
Operating Income | ||||||
Operating Expenses |
(75)
|
(80)
|
(89)
|
(113)
|
(101)
|
|
Selling, General & Administrative |
(50)
|
(53)
|
(59)
|
(78)
|
(71)
|
|
Research & Development |
(17)
|
(25)
|
(26)
|
(39)
|
(40)
|
|
Depreciation & Amortization |
(12)
|
0
|
(14)
|
0
|
0
|
|
Other Operating Expenses |
5
|
(2)
|
10
|
4
|
10
|
|
Operating Income |
101
N/A
|
101
0%
|
99
-2%
|
119
+20%
|
63
-47%
|
|
Pre-Tax Income | ||||||
Interest Income Expense |
4
|
10
|
17
|
25
|
36
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
6
|
2
|
4
|
4
|
1
|
|
Pre-Tax Income |
111
N/A
|
114
+2%
|
119
+5%
|
147
+23%
|
100
-32%
|
|
Net Income | ||||||
Tax Provision |
(17)
|
(16)
|
(14)
|
(17)
|
(11)
|
|
Income from Continuing Operations |
95
|
97
|
105
|
129
|
90
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
95
N/A
|
97
+3%
|
105
+8%
|
130
+23%
|
90
-31%
|
|
EPS (Diluted) |
1.16
N/A
|
0.84
-28%
|
0.92
+10%
|
1.12
+22%
|
0.78
-30%
|